Teclistamab (Anti-BCMA & CD3)
Product Specifications
CAS Number
2119595-80-9
Synonyms
JNJ-64007957
SKU
C00893-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Teclistamab is a humanized bispecific IgG4 monoclonal antibody that targets CD3 on T cells and B-cell maturation antigen (BCMA) on multiple myeloma (MM) cells. It triggers a T cell-mediated immune response, leading to the elimination of BCMA-positive cells and exhibits the potential to treat patients with triple-class exposed relapsed/refractory multiple myeloma (R/RMM) . MW: 143.66 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
